We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.

Oncology Drug Reference Sheet: Decitabine and Cedazuridine

By: Kristine B. LeFebvre DNP, RN, NPD-BC, AOCN®

Published In: Voice

Publication Date: 2021-03-30

Description

In July 2020, the U.S. Food and Drug Administration approved decitabine and cedazuridine (Inqovi^®) tablets for the treatment of adults with myelodysplastic syndromes (MDS).

View Article @ voice.ons.org

ONS Drug Education

Short summaries of newly approved oncology-related therapies or drugs with new indications.

View All Drug Education

Oncology Drug Reference Sheet: Decitabine and Cedazuridine

Description

ONS Drug Education

Related Topics